Novo Nordisk(NVO) - 2023 Q2 - Earnings Call Presentation

1 Investor presentation First six months of 2023 RAFAEL VALVERDE Rafael lives with obesity Mexico Novo Nordisk –a focused healthcare company Investor presentation First six months of 2023 2 Novo Nordisk® Investor presentation First six months of 2023 Agenda Progress on Strategic Aspirations 2025 Commercial execution Agenda Innovation and therapeutic focus Financials 3 Novo Nordisk® Investor presentation First six months of 2023 Forward-looking statements Novo Nordisk's reports filed with or furnished to the ...